These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 17825685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A therapy for cervical dystonia.
    Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J.
    Cochrane Database Syst Rev; 2020 Nov 12; 11(11):CD003633. PubMed ID: 33180963
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type B for cervical dystonia.
    Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD004315. PubMed ID: 15674941
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
    Han Y, Stevens AL, Dashtipour K, Hauser RA, Mari Z.
    J Neurol; 2016 Apr 25; 263(4):772-80. PubMed ID: 26914922
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A therapy for cervical dystonia.
    Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003633. PubMed ID: 15674910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystonia.
    Dressler D.
    J Neurol Neurosurg Psychiatry; 2002 Nov 25; 73(5):604; author reply 604. PubMed ID: 12397170
    [No Abstract] [Full Text] [Related]

  • 14. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
    Dressler D, Hallett M.
    Eur J Neurol; 2006 Feb 25; 13 Suppl 1():11-5. PubMed ID: 16417592
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.
    Brashear A.
    Expert Opin Drug Saf; 2005 Mar 25; 4(2):241-9. PubMed ID: 15794717
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical experience of dose conversion ratios between 2 botulinum toxin products in the treatment of cervical dystonia.
    Rystedt A, Nyholm D, Naver H.
    Clin Neuropharmacol; 2012 Mar 25; 35(6):278-82. PubMed ID: 23123690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.